{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:49:28Z","timestamp":1790876968007,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T00:00:00Z","timestamp":1430179200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>DDX3 belongs to DEAD box RNA helicase family and is involved in the progression of several types of cancer. In this work, we employed a High Throughput Virtual screening approach to identify bioactive compounds against DDX3 from ZINC natural database. Ketorolac salt was selected based on its binding free energy less than or equals to \u22125\u2005Kcal\/mol with reference to existing synthetic DDX3 inhibitors and strong hydrogen bond interactions as similar to crystallized DDX3 protein (2I4I). The anti-cancer activity of Ketorolac salt against DDX3 was tested using oral squamous cell carcinoma (OSCC) cell lines. This compound significantly down regulated the expression of DDX3 in human OSCC line (H357) and the half maximal growth inhibitory concentration (IC<jats:sub>50<\/jats:sub>) of Ketorolac salt in H357 cell line is 2.6\u2005\u00b5M. Ketorolac salt also inhibited the ATP hydrolysis by directly interacting with DDX3. More importantly, we observed decreased number of neoplastic tongue lesions and reduced lesion severity in Ketorolac salt treated groups in a carcinogen induced tongue tumor mouse model. Taken together, our result demonstrates that Ketorolac salt is a newly discovered bioactive compound against DDX3 and this compound can be used as an ideal drug candidate to treat DDX3 associated oral cancer.<\/jats:p>","DOI":"10.1038\/srep09982","type":"journal-article","created":{"date-parts":[[2015,4,28]],"date-time":"2015-04-28T14:46:39Z","timestamp":1430232399000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer"],"prefix":"10.1038","volume":"5","author":[{"given":"Sabindra K.","family":"Samal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samapika","family":"Routray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ganesh Kumar","family":"Veeramachaneni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupesh","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahendran","family":"Botlagunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,28]]},"reference":[{"key":"BFsrep09982_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.4161\/cib.13844","volume":"4","author":"P Umate","year":"2011","unstructured":"Umate, P., Tuteja, N. & Tuteja, R. Genome-wide comprehensive analysis of human helicases. Commun. Integr. Biol. 4, 118\u2013137 (2011).","journal-title":"Commun. Integr. Biol."},{"key":"BFsrep09982_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-1119(03)00626-7","volume":"312","author":"E Silverman","year":"2003","unstructured":"Silverman, E., Edwalds-Gilbert, G. & Lin, R. J. DExD\/H-box proteins and their partners: helping RNA helicases unwind. Gene. 312, 1\u201316 (2003).","journal-title":"Gene."},{"key":"BFsrep09982_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.gene.2005.10.019","volume":"367","author":"O Cordin","year":"2006","unstructured":"Cordin, O., Banroques, J., Tanner, N. K. & Linder, P. The DEAD-box protein family of RNA helicases. Gene. 367, 17\u201337 (2006).","journal-title":"Gene."},{"key":"BFsrep09982_CR4","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrm1335","volume":"5","author":"S Rocak","year":"2004","unstructured":"Rocak, S. & Linder, P. DEAD-box proteins: the driving forces behind RNA metabolism. Nat. Rev. Mol. Cell Biol. 5, 232\u2013241 (2004).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"BFsrep09982_CR5","doi-asserted-by":"publisher","first-page":"5201","DOI":"10.1073\/pnas.94.10.5201","volume":"94","author":"J de la Cruz","year":"1997","unstructured":"de la Cruz, J., Iost, I., Kressler, D. & Linder, P. The p20 and Ded1 proteins have antagonistic roles in eIF4E-dependent translation in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 94, 5201\u20135206 (1997).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep09982_CR6","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S1097-2765(01)00329-X","volume":"8","author":"NK Tanner","year":"2001","unstructured":"Tanner, N. K. & Linder, P. DExD\/H box RNA helicases: from generic motors to specific dissociation functions. Mol. Cell. 8, 251\u2013262 (2001).","journal-title":"Mol. Cell."},{"key":"BFsrep09982_CR7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1159\/000015022","volume":"81","author":"SH Park","year":"1998","unstructured":"Park, S. H., Lee, S. G., Kim, Y. & Song, K. Assignment of a human putative RNA helicase gene, DDX3, to human X chromosome bands p11.3--&gt;p11.23. Cytogenet Cell. Genet. 81, 178\u2013179 (1998).","journal-title":"Cytogenet Cell. Genet."},{"key":"BFsrep09982_CR8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1016-8478(23)17085-3","volume":"12","author":"YS Kim","year":"2001","unstructured":"Kim, Y. S., Lee, S. G., Park, S. H. & Song, K. Gene structure of the human DDX3 and chromosome mapping of its related sequences. Mol. Cells 12, 209\u2013214 (2001).","journal-title":"Mol. Cells"},{"key":"BFsrep09982_CR9","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jmb.2007.06.050","volume":"372","author":"M Hogbom","year":"2007","unstructured":"Hogbom, M. et al. Crystal structure of conserved domains 1 and 2 of the human DEAD-box helicase DDX3X in complex with the mononucleotide AMP. J. Mol. Biol. 372, 150\u2013159 (2007).","journal-title":"J. Mol. Biol."},{"key":"BFsrep09982_CR10","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/0378-1119(94)90541-X","volume":"140","author":"SL Gee","year":"1994","unstructured":"Gee, S. L. & Conboy, J. G. Mouse erythroid cells express multiple putative RNA helicase genes exhibiting high sequence conservation from yeast to mammals. Gene. 140, 171\u2013177 (1994).","journal-title":"Gene."},{"key":"BFsrep09982_CR11","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1038\/onc.2008.33","volume":"27","author":"M Botlagunta","year":"2008","unstructured":"Botlagunta, M. et al. Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene. 27, 3912\u20133922 (2008).","journal-title":"Oncogene."},{"key":"BFsrep09982_CR12","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1172\/JCI59218","volume":"122","author":"T Celia-Terrassa","year":"2012","unstructured":"Celia-Terrassa, T. et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J. Clin. Invest. 122, 1849\u20131868 (2012).","journal-title":"J. Clin. Invest."},{"key":"BFsrep09982_CR13","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1158\/0008-5472.CAN-07-2017","volume":"68","author":"D Sarrio","year":"2008","unstructured":"Sarrio, D. et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 68, 989\u2013997 (2008).","journal-title":"Cancer Res."},{"key":"BFsrep09982_CR14","first-page":"117","volume":"3","author":"LJ Talbot","year":"2012","unstructured":"Talbot, L. J., Bhattacharya, S. D. & Kuo, P. C. Epithelial-mesenchymal transition, the tumor microenvironment and metastatic behavior of epithelial malignancies. Int. J. Biochem. Mol. Biol. 3, 117\u2013136 (2012).","journal-title":"Int. J. Biochem. Mol. Biol."},{"key":"BFsrep09982_CR15","first-page":"125","volume":"8","author":"BA Teicher","year":"1994","unstructured":"Teicher, B. A. et al. Reduced oxygenation in a rat mammary carcinoma post-radiation and reoxygenation with a perflubron emulsion\/carbogen breathing. In Vivo. 8, 125\u2013131 (1994).","journal-title":"In Vivo."},{"key":"BFsrep09982_CR16","first-page":"5754","volume":"56","author":"TY Reynolds","year":"1996","unstructured":"Reynolds, T. Y., Rockwell, S. & Glazer, P. M. Genetic instability induced by the tumor microenvironment. Cancer Res. 56, 5754\u20135757 (1996).","journal-title":"Cancer Res."},{"key":"BFsrep09982_CR17","first-page":"941","volume":"56","author":"DM Brizel","year":"1996","unstructured":"Brizel, D. M. et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941\u2013943 (1996).","journal-title":"Cancer Res."},{"key":"BFsrep09982_CR18","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1152\/jappl.2000.88.4.1474","volume":"88","author":"GL Semenza","year":"2000","unstructured":"Semenza, G. L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88, 1474\u20131480 (2000).","journal-title":"J. Appl. Physiol."},{"key":"BFsrep09982_CR19","doi-asserted-by":"publisher","first-page":"e17563","DOI":"10.1371\/journal.pone.0017563","volume":"6","author":"M Botlagunta","year":"2011","unstructured":"Botlagunta, M. et al. Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells. PLoS. One 6, e17563 (2011).","journal-title":"PLoS. One"},{"key":"BFsrep09982_CR20","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1038\/sj.onc.1209239","volume":"25","author":"PC Chang","year":"2006","unstructured":"Chang, P. C. et al. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene. 25, 1991\u20132003 (2006).","journal-title":"Oncogene."},{"key":"BFsrep09982_CR21","doi-asserted-by":"publisher","first-page":"6579","DOI":"10.1158\/0008-5472.CAN-05-2415","volume":"66","author":"CH Chao","year":"2006","unstructured":"Chao, C. H. et al. DDX3, a DEAD box RNA helicase with tumor growth-suppressive property and transcriptional regulation activity of the p21waf1\/cip1 promoter, is a candidate tumor suppressor. Cancer Res. 66, 6579\u20136588 (2006).","journal-title":"Cancer Res."},{"key":"BFsrep09982_CR22","doi-asserted-by":"publisher","first-page":"e19810","DOI":"10.1371\/journal.pone.0019810","volume":"6","author":"A Garbelli","year":"2011","unstructured":"Garbelli, A., Beermann, S., Di Cicco, G., Dietrich, U. & Maga, G. A motif unique to the human DEAD-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA\/DNA unwinding and HIV-1 replication. PLoS. One 6, e19810 (2011).","journal-title":"PLoS. One"},{"key":"BFsrep09982_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.cell.2004.09.029","volume":"119","author":"VS Yedavalli","year":"2004","unstructured":"Yedavalli, V. S., Neuveut, C., Chi, Y. H., Kleiman, L. & Jeang, K. T. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell. 119, 381\u2013392 (2004).","journal-title":"Cell."},{"key":"BFsrep09982_CR24","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1158\/1940-6207.CAPR-08-0147","volume":"2","author":"R Czerninski","year":"2009","unstructured":"Czerninski, R., Amornphimoltham, P., Patel, V., Molinolo, A. A. & Gutkind, J. S. Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model. Cancer prevention research 2, 27\u201336, 10.1158\/1940-6207.CAPR-08-0147 (2009).","journal-title":"Cancer prevention research"},{"key":"BFsrep09982_CR25","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0969-2126(98)00010-0","volume":"6","author":"JL Kim","year":"1998","unstructured":"Kim, J. L. et al. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 6, 89\u2013100 (1998).","journal-title":"Structure"},{"key":"BFsrep09982_CR26","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/333022b0","volume":"333","author":"TC Hodgman","year":"1988","unstructured":"Hodgman, T. C. A new superfamily of replicative proteins. Nature 333, 22\u201323 (1988).","journal-title":"Nature"},{"key":"BFsrep09982_CR27","doi-asserted-by":"publisher","first-page":"4933","DOI":"10.1016\/j.bmc.2007.04.043","volume":"15","author":"P Zhang","year":"2007","unstructured":"Zhang, P., Zhang, N., Buckwold, V. E. & Hosmane, R. S. Chemical and biological effects of substitution of the 2-position of ring-expanded (\u2018fat\u2019) nucleosides containing the imidazo[4,5-e][1,3]diazepine-4,8-dione ring system: the role of electronic and steric factors on glycosidic bond stability and anti-HCV activity. Bioorg. Med. Chem. 15, 4933\u20134945 (2007).","journal-title":"Bioorg. Med. Chem."},{"key":"BFsrep09982_CR28","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1021\/jm030842j","volume":"46","author":"N Zhang","year":"2003","unstructured":"Zhang, N. et al. Ring-expanded (\"fat\") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases\/helicases, including those of the West Nile virus, hepatitis C virus and Japanese encephalitis virus. J. Med. Chem. 46, 4149\u20134164 (2003).","journal-title":"J. Med. Chem."},{"key":"BFsrep09982_CR29","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1021\/jm800332m","volume":"51","author":"VS Yedavalli","year":"2008","unstructured":"Yedavalli, V. S. et al. Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication. J. Med. Chem. 51, 5043\u20135051 (2008).","journal-title":"J. Med. Chem."},{"key":"BFsrep09982_CR30","doi-asserted-by":"publisher","first-page":"2931","DOI":"10.1016\/S0968-0896(99)00235-7","volume":"7","author":"M Bretner","year":"1999","unstructured":"Bretner, M., Beckett, T. D., Sood, R. K., Baldisseri, D. M. & Hosmane, R. S. Substrate\/inhibition studies of bacteriophage T7 RNA polymerase with the 5'-triphosphate derivative of a ring-expanded (\u2018fat\u2019) nucleoside possessing potent antiviral and anticancer activities. Bioorg. Med. Chem. 7, 2931\u20132936 (1999).","journal-title":"Bioorg. Med. Chem."},{"key":"BFsrep09982_CR31","doi-asserted-by":"publisher","first-page":"4681","DOI":"10.1021\/ol8020176","volume":"10","author":"R Kumar","year":"2008","unstructured":"Kumar, R., Ujjinamatada, R. K. & Hosmane, R. S. The first synthesis of a novel 5:7:5-fused diimidazodiazepine ring system and some of its chemical properties. Org. Lett. 10, 4681\u20134684 (2008).","journal-title":"Org. Lett."},{"key":"BFsrep09982_CR32","doi-asserted-by":"publisher","first-page":"4776","DOI":"10.1021\/jm030277k","volume":"46","author":"N Zhang","year":"2003","unstructured":"Zhang, N. et al. Potent inhibition of NTPase\/helicase of the West Nile Virus by ring-expanded (\u2018fat\u2019) nucleoside analogues. J. Med. Chem. 46, 4776\u20134789 (2003).","journal-title":"J. Med. Chem."},{"key":"BFsrep09982_CR33","doi-asserted-by":"publisher","first-page":"6635","DOI":"10.1021\/jm8008844","volume":"51","author":"G Maga","year":"2008","unstructured":"Maga, G. et al. Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3. J. Med. Chem. 51, 6635\u20136638 (2008).","journal-title":"J. Med. Chem."},{"key":"BFsrep09982_CR34","doi-asserted-by":"publisher","first-page":"5129","DOI":"10.1016\/j.bmc.2010.05.066","volume":"18","author":"A Najda-Bernatowicz","year":"2010","unstructured":"Najda-Bernatowicz, A., Krawczyk, M., Stankiewicz-Drogon, A., Bretner, M. & Boguszewska-Chachulska, A. M. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication. Bioorg. Med. Chem. 18, 5129\u20135136 (2010).","journal-title":"Bioorg. Med. Chem."},{"key":"BFsrep09982_CR35","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1021\/ml100281b","volume":"2","author":"A Kondaskar","year":"2010","unstructured":"Kondaskar, A. et al. Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System. ACS Med. Chem. Lett. 2, 252\u2013256 (2010).","journal-title":"ACS Med. Chem. Lett."},{"key":"BFsrep09982_CR36","doi-asserted-by":"publisher","first-page":"19","DOI":"10.4103\/2152-7806.92935","volume":"3","author":"RL Blaylock","year":"2012","unstructured":"Blaylock, R. L. & Maroon, J. Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Surg. Neurol. Int. 3, 19 (2012).","journal-title":"Surg. Neurol. Int."},{"key":"BFsrep09982_CR37","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/1752-153X-6-94","volume":"6","author":"SN Razzaq","year":"2012","unstructured":"Razzaq, S. N., Khan, I. U., Mariam, I. & Razzaq, S. S. Stability indicating HPLC method for the simultaneous determination of moxifloxacin and prednisolone in pharmaceutical formulations. Chem. Cent. J. 6, 94, 10.1186\/1752-153X-6-94 (2012).","journal-title":"Chem. Cent. J."},{"key":"BFsrep09982_CR38","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/ibd.21511","volume":"17","author":"NA Molodecky","year":"2011","unstructured":"Molodecky, N. A., Panaccione, R., Ghosh, S., Barkema, H. W. & Kaplan, G. G. Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm. Bowel. Dis. 17, 1792\u20131799, 10.1002\/ibd.21511 (2011).","journal-title":"Inflamm. Bowel. Dis."},{"key":"BFsrep09982_CR39","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","volume":"454","author":"A Mantovani","year":"2008","unstructured":"Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436\u2013444, 10.1038\/nature07205 (2008).","journal-title":"Nature"},{"key":"BFsrep09982_CR40","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nrc704","volume":"2","author":"AL Harris","year":"2002","unstructured":"Harris, A. L. Hypoxia--a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38\u201347, 10.1038\/nrc704 (2002).","journal-title":"Nat. Rev. Cancer"},{"key":"BFsrep09982_CR41","doi-asserted-by":"publisher","first-page":"790","DOI":"10.2174\/187152008785914798","volume":"8","author":"JP Cosse","year":"2008","unstructured":"Cosse, J. P. & Michiels, C. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med. Chem. 8, 790\u2013797 (2008).","journal-title":"Anticancer Agents Med. Chem."},{"key":"BFsrep09982_CR42","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1038\/cdd.2008.124","volume":"15","author":"M Sun","year":"2008","unstructured":"Sun, M., Song, L., Li, Y., Zhou, T. & Jope, R. S. Identification of an antiapoptotic protein complex at death receptors. Cell. Death Differ. 15, 1887\u20131900 (2008).","journal-title":"Cell. Death Differ."},{"key":"BFsrep09982_CR43","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s10549-012-2094-5","volume":"134","author":"M Retsky","year":"2012","unstructured":"Retsky, M. et al. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res. Treat. 134, 881\u2013888, 10.1007\/s10549-012-2094-5 (2012).","journal-title":"Breast Cancer Res. Treat."},{"key":"BFsrep09982_CR44","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1021\/ct900587b","volume":"6","author":"DWJ; Shivakumar","year":"2010","unstructured":"Shivakumar, D. W. J. ;. Wu, Y. ;. Damm, W. ;. Shelley, J. ;. Sherman, W. Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field. Journal of Chemical Theory and Computation 6, 1509\u20131519 (2010).","journal-title":"Journal of Chemical Theory and Computation"},{"key":"BFsrep09982_CR45","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1021\/jm030644s","volume":"47","author":"TA Halgren","year":"2004","unstructured":"Halgren, T. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750\u20131759, 10.1021\/jm030644s (2004).","journal-title":"J. Med. Chem."},{"key":"BFsrep09982_CR46","doi-asserted-by":"crossref","unstructured":"Leelahavanichkul, K. & Gutkind, J. S. Oral and pharyngeal epithelial keratinocyte culture. Methods. Mol. Biol. 945, 67\u201379, doi:10.1007\/978-1-62703-125-7_5 (2013).","DOI":"10.1007\/978-1-62703-125-7_5"},{"key":"BFsrep09982_CR47","doi-asserted-by":"publisher","first-page":"8785","DOI":"10.1073\/pnas.1100769108","volume":"108","author":"R Dash","year":"2011","unstructured":"Dash, R. et al. Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7\/IL-24-mediated toxicity. Proc. Natl. Acad. Sci. U. S. A. 108, 8785\u20138790, 10.1073\/pnas.1100769108 (2011).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"BFsrep09982_CR48","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1042\/BJ20090817","volume":"423","author":"TK Beuria","year":"2009","unstructured":"Beuria, T. K., Singh, P., Surolia, A. & Panda, D. Promoting assembly and bundling of FtsZ as a strategy to inhibit bacterial cell division: a new approach for developing novel antibacterial drugs. Biochem. J. 423, 61\u201369, 10.1042\/BJ20090817 (2009).","journal-title":"Biochem. J."},{"key":"BFsrep09982_CR49","doi-asserted-by":"crossref","unstructured":"Beuria, T. K., Santra, M. K. & Panda, D. Sanguinarine blocks cytokinesis in bacteria by inhibiting FtsZ assembly and bundling. Biochemistry 44, 16584\u201316593, doi:10.1021\/bi050767+ (2005).","DOI":"10.1021\/bi050767+"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep09982.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep09982","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep09982.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T17:08:47Z","timestamp":1717866527000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep09982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2015,9,22]]}},"alternative-id":["BFsrep09982"],"URL":"https:\/\/doi.org\/10.1038\/srep09982","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,28]]},"assertion":[{"value":"26 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author(s) declare that no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9982"}}